,
4
7
3
,
4
7
4
t
,
4
7
6
R
o
m
i
d
e
p
s
i
n
,
4
6
9
t
R
o
p
i
n
i
r
o
l
e
,
1
2
5
0
t
,
1
2
5
4
–
1
2
5
5
,
1
2
5
4
t
,
1
2
6
1
,
1
9
0
6
t
R
o
p
i
v
a
c
a
i
n
e
,
1
1
7
7
t
R
o
s
i
g
l
i
t
az
o
n
e
,
1
1
2
3
,
1
1
2
4
,
1
1
2
5
fo
r
H
F
,
2
7
5
R
o
s
u
v
a
s
t
a
t
i
n
,
4
4
,
4
6
t
,
1
1
0
t
,
1
1
6
,
1
1
7
t
,
1
2
0
t
,
9
4
2
t
R
o
t
a
ri
x
(
R
V
1
)
,
1
3
6
1
R
o
t
a
T
e
q
,
1
3
6
1
R
o
t
av
i
r
u
s
v
a
c
c
i
n
e
,
1
3
5
5
R
o
t
i
g
o
t
i
n
e
,
1
2
5
1
t
,
1
2
5
4
t
,
1
2
5
5
,
1
2
6
1
–
1
2
6
2
R
o
wa
s
a
(
s
e
e
M
e
s
a
l
a
m
i
n
e
e
n
e
m
a)
R
o
z
e
r
e
m
(
s
e
e
R
a
m
e
l
t
e
o
n
)
R
P
V
(
s
e
e
R
i
l
p
i
v
i
ri
n
e
(
R
P
V)
)
R
T
V
(
s
e
e
R
i
t
o
n
av
i
r
(
R
T
V)
)
R
u
c
a
p
a
ri
b
,
4
7
0
t
R
u
fi
n
a
m
i
d
e
,
9
4
2
t
,
1
2
7
9
t
p. 2
3
1
3
p. 2
3
1
4
Ruxolitinib, 470t
RV1 (see Rotarix (RV1))
Ryzodeg, 1087
S
Sacubitril/valsartan (Entresto), 273
Safinamide, 1251t, 1264
Salicylates, 849t, 852, 1187t, 1626, 1652, 2131t
ingestion of, assessment of, 67–70
Salicylic acid, 827–828, 942t
Saline, 589–590, 589t
Salmeterol
for chronic asthma, 396–397
for COPD, 421, 421t, 422
for EIA, 401
Salsalate, 888t
Saphris (see Asenapine)
Saquinavir (SQV), 128, 942t, 1579t
Sarafem (see Fluoxetine)
Saxagliptin, 128, 1127–1128
for type 2 diabetes, 1135
Saxenda (see Liraglutide)
Scopolamine (Transderm-Scop), 468t
for end-of-life care, 89
for PONV, 478t
Second-generation triptans, 1239
Secukinumab, 842–843
Sedating drugs, 552
Sedatives, 552
Selective estrogen receptor modulators (SERMs), 2271
Selective phosphodiesterase 4 (PDE4) inhibitors, 417
Selective serotonin reuptake inhibitors (SSRIs), 1749
adverse effects, 1758–1759
for anxiety, 1859
for ASD, 1858
for bipolar depression, 1837
for critically ill patients, 1208
for depression, 1859
for depressive disorders, 1820
dosage, 1758
for hot flushes, 1036
and lithium, 1843t
for OCD, 1758
for panic disorder, 1748, 1749
for PMDD, 1025
for PTSD, 1754
and sexual response, 2261t
and sleep, 1774
Selegiline, 942t, 1251t, 1255, 1264
Selenium, 961
for prostate cancer, 2099
Senna, 2159t
Septra (see Trimethoprim-sulfamethoxazole (TMP-SMX))
SERMs (see Selective estrogen receptor modulators (SERMs))
Seroquel (see Quetiapine)
Serotonin, 1224
androgen deprivation therapy, 2097
Serotonin and norepinephrine reuptake inhibitors (SNRIs), 1748
androgen deprivation therapy, 2097
for critically ill patients, 1208
for hot flushes, 1036
for stress incontinence, 2252
Serotonin (5-HT) receptors
LSD, 1886
Sertraline (Zoloft), 1027t, 1738t, 1748, 1749
for depression, 2245
for depressive disorders, 1819t, 1820t, 1821t
for diabetes, 2226t
for OCD, 1760
for panic disorder, 1748
for prostate cancer, 2086
for SAD, 1752
and sleep, 1774
in treatment of IDH, 657
for vasomotor symptoms, 1036t
Serum aminoglycoside, 461–462
Serum immunoglobulin E antibodies, 455–456
Serum precipitins, 455–456
Serzone (see Nefazodone)
Sevelamer, 619–620
carbonate, 620t
hydrochloride, 620t
17-α hydroxyprogesterone (17-OHP), 995–996
Sildenafil, 924, 2265
and ED, 2265
Silenor (see Doxepin)
Silodosin, 2257
for BPH, 2257
Siltuximab, 469t
Silvadene (see Silver sulfadiazine cream)
Silver sulfadiazine cream (Silvadene; Aquacel Ag; ConvaTec), 863
Simeprevir, 1687–1688
Simvastatin, 46t, 55, 57, 57t, 110t, 116, 117, 117t, 120t, 125, 258
Sinecatechins, 1532
Sinemet CR (see Carbidopa–Levodopa (CR))
Singulair (see Montelukast)
Sipuleucel-T, 2095
Sirolimus, 120t, 128, 226, 722
Sitagliptin, 128, 1127–1128
for type 2 diabetes, 1135, 1139
Sivestro (see Tedizolid)
6-mercaptopurine (6-MP)
for Crohn’s disease, 529–531
for inflammatory bowel disease, 521t, 523–524
for T-cell lymphomas, 2020t
Skyla, 948
SMX (see Sulfamethoxazole (SMX))
SNRIs (see Serotonin and norepinephrine reuptake inhibitors (SNRIs))
Sodium
and children, 2140t
loss due to diarrhea, 2142
in oral electrolyte solutions, 2161t
and respiratory alkalosis, 1672
in WHO formula, 2160
Sodium bicarbonate, 643, 977
adverse effects of, 361
-carbonic acid system, 611
hyperkalemia and, 586, 587t
in metabolic acidosis, 562–563
for preventing SRMB, 515t
for salicylate toxicity, 70
for TCA toxicity, 77–78
Sodium carbonate, 1916
Sodium ferric gluconate complex, 614
Sodium–glucose transporter 2 (SGLT2) inhibitors
adverse effects of, 1130
contraindications and precautions of, 1130
for diabetes, 2225
dosage and clinical use, 1130
drug interactions, 1130
efficacy of, 1130
pharmacokinetics of, 1129–1130
Sodium oxybate, 1778–1779
Sodium polystyrene sulfonate (SPS), 586
for hyperkalemia, 587t
side effects, 586
Sodium stibogluconate, 1705t
Sodium thiosulfate, 1624t
Sodium zirconium cyclosilicate, for hyperkalemia, 586
Sofosbuvir, 1688–1689
Solifenacin, 2251–2252
Somatostatin
analogues, 502
for variceal bleeding, 513
Sonata (see Zaleplon)
Sonidegib, 470t
Sorafenib (Nexavar), 470t, 1990
Sorbitol, 67, 2156t
Sordarins, 1626
Sotalol
for AF, 316–317
and QTc, 327
for tachycardia, 1802
Spectinomycin, 1508
Spectracef (see Cefditoren)
Spectrobid (see Bacampicillin)
Spiriva Respimat, for asthma, 399
Spironolactone (Antiandrogen), 543, 546, 580–581, 2261t
for acne, 829
for hirsutism, 1012
for hypertension, 140, 157
for polycystic ovary syndrome, 1012t
Sprycel (see Dasatinib)
SPS (see Sodium polystyrene sulfonate (SPS))
SQV (see Saquinavir)
S
S
R
I
s
(
s
e
e
S
e
l
e
c
t
i
v
e
s
e
r
o
t
o
n
i
n
r
e
u
p
t
a
k
e
i
n
h
i
b
i
t
o
r
s
(
S
S
R
I
s
)
)
S
S
Z
(
s
e
e
S
u
l
fa
s
a
l
azi
n
e
(
S
S
Z)
)
S
t
a
r
c
h
,
1
6
2
7
S
t
a
t
i
n
s
,
3
7
3
S
t
av
u
d
i
n
e
(
d
4
T
)
,
fo
r
H
I
V,
9
9
6
,
1
5
7
7
t
S
t
e
r
o
i
d
s
fo
r
s
e
p
t
ic
s
h
o
c
k
,
3
7
2
S
No comments:
Post a Comment
اكتب تعليق حول الموضوع